Sponsor Dossier
DEMOGEN Pharmaceuticals
Sponsor Dossier for DEMOGEN Pharmaceuticals. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ACICLOVIR DEMOGEN
- Brand: AMIKACIN DEMOGEN
- Brand: BENZYLPENICILLIN DEMOGEN
- Brand: CASPOFUNGIN DEMOGEN
- Brand: CEFAZOLIN DEMOGEN
- Brand: CEFEPIME DEMOGEN
- Brand: CEFTRIAXONE
- Brand: CIPROFLOXACIN DEMOGEN
About
Demogen Pharmaceuticals is an Australian Private Company with ABN 77681420280, registered in NSW. The entity is active and operates under the trading name DEMOGEN Pharmaceuticals.
Portfolio
Demogen Pharmaceuticals has 19 brands on the ARTG, of which 17 are indexable. Sixteen brands have Product Information on file. One brand has at least one PBS-listed item. No brands have PBAC outcomes or AusPARs on record.
Therapeutic focus
— Infectious Disease: 9 brands — Pain & Anaesthesia: 3 brands — Gastroenterology: 2 brands — Other: 1 brand — Respiratory: 1 brand — Pain Management: 1 brand — Neurology: 1 brand — Haematology: 1 brand
PBS footprint
One brand in the Demogen Pharmaceuticals portfolio is PBS-listed. The latest PBS schedule date the portfolio touched was 2026-05-01.